Stedman’s Medical Dictionary. 2000. Philadelphia: Lippincott Williams & Wilkins.

Stone AA, Shiffman S. 2002. Capturing momentary self-report data: a proposal for reporting guidelines. Annals of Behavioral Medicine 24(3):236–243.


Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA Jr. 2003. The influence of finasteride on the development of prostate cancer. New England Journal of Medicine 349(3):215–224.


Vermeulen A. 2001. Androgen replacement therapy in the aging male––a critical evaluation. Journal of Clinical Endocrinology and Metabolism 86(6):2380–2390.

Vermeulen A, Kaufman JM. 1995. Ageing of the hypothalamo-pituitary-testicular axis in men. Hormone Research 43(1–3):25–28.


Wang C, Swedloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. 2000. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. Journal of Clinical Endocrinology and Metabolism 85(8):2839–2853.

Winkler UH. 1996. Effects of androgens on haemostasis. Maturitas 24(3):147–155.

Wright EJ, Fang J, Metter EJ, Partin AW, Landis P, Chan DW, Carter HB. 2002. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore Longitudinal Study of Aging. Journal of Urology 167(6):2484–2488.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement